Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg

被引:6
作者
Friedrich, Reinhard E. [1 ]
Hagel, Christian [2 ]
Kohlrusch, Felix K. [1 ]
Schanze, Ina [3 ]
Wieland, Ilse [3 ]
Zenker, Martin [3 ]
机构
[1] Univ Hamburg, Eppendorf Univ Hosp, Dept Oral & Craniomaxillofacial Surg, Hamburg, Germany
[2] Univ Hamburg, Eppendorf Univ Hosp, Inst Neuropathol, Hamburg, Germany
[3] Otto von Guericke Univ, Inst Human Genet, Magdeburg, Germany
关键词
Neurofbromatosis type 1; tumour predisposition syndrome; mosaicism; plexiform neurofibroma; NERVE SHEATH TUMORS; MUTATION; GENE; NF1; PATIENT;
D O I
10.21873/anticanres.14327
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant hereditary disease with complete penetrance and a very variable phenotype. Recent research has shown that postzygotic NF1 gene mutations occur to a far greater extent than previously thought. The phenotype of affected individuals reflects the time of somatic mutation and the phenotype is correspondingly diverse. This report describes histological and genetic findings in a case of mosaic NF1, the clinical control of which documents almost stationary skin findings over a period of 9 years. Case Report: The 55-year-old female first presented for advice on a strip of nodular skin tumours of the calf skin. She had no hallmarks of NF1. It was only 9 years later that she had the skin tumours removed, all of which were partially diffuse and partially plexiform neurofibroma. The genetic examination showed an atypical large deletion of the NF1 gene in the skin tumours, but not in overlying skin or blood. Conclusion: Segmental NF1 is a distinct type of mosaic/somatic NF1 mutation. The phenotype of diffuse and plexiform skin neurofibromas can resemble cutaneous neurofibroma. Surgical therapy for segmental neurofibromatosis does not differ from the concepts for treating nerve sheath tumours in NF1 patients with a germline NF1 mutation.
引用
收藏
页码:3423 / 3427
页数:5
相关论文
共 25 条
[1]  
Antonescu C, 2013, AFIP ATLAS TUMOUR PA, V4
[2]  
Buske A, 1999, AM J MED GENET, V86, P328, DOI 10.1002/(SICI)1096-8628(19991008)86:4<328::AID-AJMG6>3.0.CO
[3]  
2-O
[4]   NEUROFIBROMIN, A PREDOMINANTLY NEURONAL GTPASE ACTIVATING PROTEIN IN THE ADULT, IS UBIQUITOUSLY EXPRESSED DURING DEVELOPMENT [J].
DASTON, MM ;
RATNER, N .
DEVELOPMENTAL DYNAMICS, 1992, 195 (03) :216-226
[5]   Malignant peripheral nerve sheath tumours in neurofibromatosis 1 [J].
Evans, DGR ;
Baser, ME ;
McGaughran, J ;
Sharif, S ;
Howard, E ;
Moran, A .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (05) :311-314
[6]  
Friedman JM., 1999, Neurofibromatosis: Phenotype, Natural History, and Pathogenesis
[7]  
Friedrich RE, 2015, ANTICANCER RES, V35, P6813
[8]   Emerging genotype-phenotype relationships in patients with large NF1 deletions [J].
Kehrer-Sawatzki, Hildegard ;
Mautner, Victor-Felix ;
Cooper, David N. .
HUMAN GENETICS, 2017, 136 (04) :349-376
[9]  
Kluwe L, 1999, GENE CHROMOSOME CANC, V24, P283, DOI 10.1002/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO
[10]  
2-K